News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Even If Donald Trump Changed The FDA Drug Approval Process, Patients Wouldn't Benefit



11/29/2016 6:44:15 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
As we begin to enter the era of the Trump presidency, a great deal of speculation is going on as to what changes our new President will or won’t make. Health care is certainly a major part of this discussion with all sorts of advice being offered from a variety of quarters. One example comes from Dr. Joseph V. Gulfo of Fairleigh Dickinson University. In a Wall Street Journal opinion piece entitled “A Trumpian Cure for the FDA’s Chronic Lethargy”, Dr. Gulfo has a couple of recommendations that Mr. Trump can make which Dr. Gulfo believes will help in the President-elect’s goal to cut red tape at the FDA and speed up the approval of life-saving medications. Most prominent is Dr. Gulfo’s desire to eliminate the FDA’s ability to “require approvals based on long-term health outcomes – a practice that dissuades development and increases the complexity, cost and duration of clinical trials.”

Read at Forbes


comments powered by Disqus
Forbes
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES